The role of concentrated growth factor on implant stability: A preliminary study - 11/09/19

Doi : 10.1016/j.jormas.2019.08.009

B. Özveri Koyuncu ^a,⁎ , K. İçpınar Çelik ^b , M. Özden Yüce ^a , T. Günbay ^a , M.E. Çömlekoğlu ^c
^a Department of Oral Surgery, School of Dentistry, Ege University, 35040, Bornova, İzmir, Turkey
^b Katip Çelebi University, Atatürk Training and Research Hospital, 35360, Çiğli, İzmir, Turkey
^c Department of Prosthodontics, School of Dentistry, Ege University, 35040, Bornova, İzmir, Turkey

^⁎Corresponding author.

Sous presse. Épreuves corrigées par l'auteur. Disponible en ligne depuis le Wednesday 11 September 2019
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Purpose

The purpose of this preliminary study was to evaluate the effect of concentrated growth factor (CGF) on dental implant stability in type 2 bone using the resonance frequency analysis (RFA) device Smartpeg®.

Methods

The researchers carried out a prospective cohort study on a sample group composed of 12 patients (mean age=67) who required dental implants. Implant socket preparation (with and without CGF) was the primary predictor variable. In each patient, two dental implants were inserted in the anterior mandible. For the test group, one dental implant socket was covered with CGF membrane, while the other socket was prepared conventionally for the control group. Implant stability, as measured by RFA, was the outcome variable. Measurements were taken using the Ostell device at the time of implant placement and at the 1st, 2nd and 4th weeks.

Results

Mean implant stability quotients (ISQs) were 67.00±4.573 for the study group and 64.75±5.065 for the control group. The difference between the two groups was not statistically significant.